help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hobby, P.
Right arrow Articles by Sutton, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hobby, P.
Right arrow Articles by Sutton, B. J.
Endocrinology Vol. 141, No. 6 2018-2026
Copyright © 2000 by The Endocrine Society


ARTICLES

Identification of an Immunodominant Region Recognized by Human Autoantibodies in a Three-Dimensional Model of Thyroid Peroxidase1

Paul Hobby2, Andrzej Gardas2, Roman Radomski, Alan M. McGregor, J. Paul Banga and Brian J. Sutton

The Randall Centre and Guy’s, King’s and St. Thomas’ School of Medicine (A.M.M., J.P.B.), King’s College London, London, United Kingdom SE1 1UL; and Medical Centre of Postgraduate Education (A.G.) and Department of Medical Informatics, Warsaw University Medical School (R.R.), 99 01-813 Warsaw, Poland

Address all correspondence and requests for reprints to: Dr. B. J. Sutton, The Randall Centre, King’s College London, New Hunt’s House, Guy’s Campus, London Bridge, London, United Kingdom SE1 1UL. E-mail: brian.sutton{at}kcl.ac.uk

Autoimmune thyroid diseases (AITD) are characterized by the presence of autoantibodies to thyroid peroxidase (TPO). This response is dominated by autoantibodies to two conformational determinants, termed A and B, that have been defined by monoclonal antibodies but whose structures and location within TPO are unknown. We have modeled the three-dimensional structure of the extracellular region of TPO, raised antisera to prominent surface structures, and identified an epitope that we show to be a critical part of the B determinant. Antibodies to this epitope inhibit the binding to TPO of human autoantibodies in virtually all serum samples from 65 patients with AITD that were tested. This first description of a model of the three-dimensional structure and location of a major autoantigenic determinant within the TPO molecule may provide structural clues for identifying causative agents or developing novel therapeutic strategies.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. Deladoey, N. Pfarr, J.-M. Vuissoz, J. Parma, G. Vassart, S. Biesterfeld, J. Pohlenz, and G. Van Vliet
Pseudodominant Inheritance of Goitrous Congenital Hypothyroidism Caused by TPO Mutations: Molecular and in Silico Studies
J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 627 - 633.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Lionaki, S. L. Hogan, R. J. Falk, M. S. Joy, H. Chin, C. E. Jennette, J. C. Jennette, and P. H. Nachman
Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case control study
Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3508 - 3515.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Dubska, J. P. Banga, D. Plochocka, G. Hoser, E. H. Kemp, B. J. Sutton, A. Gardas, and M. Gora
Structural Insights into Autoreactive Determinants in Thyroid Peroxidase Composed of Discontinuous and Multiple Key Contact Amino Acid Residues Contributing to Epitopes Recognized by Patients' Autoantibodies
Endocrinology, December 1, 2006; 147(12): 5995 - 6003.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. A. Rebuffat, D. Bresson, B. Nguyen, and S. Peraldi-Roux
The key residues in the immunodominant region 353-363 of human thyroid peroxidase were identified
Int. Immunol., July 1, 2006; 18(7): 1091 - 1099.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Bresson, S. A. Rebuffat, B. Nguyen, J. P. Banga, A. Gardas, and S. Peraldi-Roux
New Insights into the Conformational Dominant Epitopes on Thyroid Peroxidase Recognized by Human Autoantibodies
Endocrinology, June 1, 2005; 146(6): 2834 - 2844.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Bresson, M. Pugniere, F. Roquet, S. A. Rebuffat, B. N-Guyen, M. Cerutti, J. Guo, S. M. McLachlan, B. Rapoport, V. Estienne, et al.
Directed Mutagenesis in Region 713-720 of Human Thyroperoxidase Assigns 713KFPED717 Residues as Being Involved in the B Domain of the Discontinuous Immunodominant Region Recognized by Human Autoantibodies
J. Biol. Chem., September 10, 2004; 279(37): 39058 - 39067.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Guo, P. N. Pichurin, J. C. Morris, B. Rapoport, and S. M. McLachlan
"Naked" Deoxyribonucleic Acid Vaccination Induces Recognition of Diverse Thyroid Peroxidase T Cell Epitopes
Endocrinology, August 1, 2004; 145(8): 3671 - 3678.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Dromey, S. M. Weenink, G. H. Peters, J. Endl, P. J. Tighe, I. Todd, and M. R. Christie
Mapping of Epitopes for Autoantibodies to the Type 1 Diabetes Autoantigen IA-2 by Peptide Phage Display and Molecular Modeling: Overlap of Antibody and T Cell Determinants
J. Immunol., April 1, 2004; 172(7): 4084 - 4090.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Bresson, M. Cerutti, G. Devauchelle, M. Pugniere, F. Roquet, C. Bes, C. Bossard, T. Chardes, and S. Peraldi-Roux
Localization of the Discontinuous Immunodominant Region Recognized by Human Anti-thyroperoxidase Autoantibodies in Autoimmune Thyroid Diseases
J. Biol. Chem., March 7, 2003; 278(11): 9560 - 9569.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Guo, S. M. McLachlan, and B. Rapoport
Localization of the Thyroid Peroxidase Autoantibody Immunodominant Region to a Junctional Region Containing Portions of the Domains Homologous to Complement Control Protein and Myeloperoxidase
J. Biol. Chem., October 18, 2002; 277(43): 40189 - 40195.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Kalafatis, P. Simioni, D. Tormene, D. O. Beck, S. Luni, and A. Girolami
Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations
Blood, May 13, 2002; 99(11): 3985 - 3992.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
V. Estienne, C. Duthoit, S. Blanchin, R. Montserret, J.-M. Durand-Gorde, M. Chartier, D. Baty, P. Carayon, and J. Ruf
Analysis of a conformational B cell epitope of human thyroid peroxidase: identification of a tyrosine residue at a strategic location for immunodominance
Int. Immunol., April 1, 2002; 14(4): 359 - 366.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Guo, X.-M. Yan, S. M. McLachlan, and B. Rapoport
Search for the Autoantibody Immunodominant Region on Thyroid Peroxidase: Epitopic Footprinting with a Human Monoclonal Autoantibody Locates a Facet on the Native Antigen Containing a Highly Conformational Epitope
J. Immunol., January 15, 2001; 166(2): 1327 - 1333.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society